Perfuze

Indonesia
Menanga, East Nusa Tenggara, Indonesia, H91 H2Y0

Company profile

Perfuze company profile

Perfuze is a neurovascular medical device company headquartered in Galway, Ireland, focused on developing innovative catheter technology to treat acute ischemic stroke. The company aims to provide superior clinical outcomes with shorter procedural times through its catheter-based aspiration technology. The proprietary platform of the company aims to optimize the efficiency of clot removal, simplify procedures, and enhance clinical results.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2018-01-01, Year

Headquarters

Postal code
H91 H2Y0
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$53.1M
Last funding
Series Unknown / $23.9M / 2025-03-13
Last equity funding
Series Unknown / $23.9M
Investors
10
Lead investors
5
Founders
2
Articles
33

Founders and investors

Founders

Liam MullinsWayne Allen

Lead investors

EarlyBirdEarlyBirdCapitalEQT Life SciencesSeroba Life SciencesSV Health Investors

Investors

EarlyBirdCapitalEnterprise IrelandEQT Life SciencesSeroba Life SciencesSV Health Investors